Emily Renda, PA
Physician Assistant · Chandler, AZNPI 1003360231
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 467 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 38 manufacturers reported payments, led by AbbVie at 27.9% of the total. 2025 is the largest year on record at $4,046, more than ten times the $143 reported in 2021. Among physician assistant clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 467 payments — averaging $25.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Takeda Pharmaceuticals U.S.A., Inc.$2K
- Johnson & Johnson$702
- Lilly USA, LLC$652
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$640
- Pfizer$636
- plus $4K from 32 others
What the payments were for
- Food & beverage$11,899100%
- Education$270%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 119 | $3,328 |
| Takeda Pharmaceuticals U.S.A., Inc. | 64 | $1,778 |
| Johnson & Johnson | 28 | $702 |
| Lilly USA, LLC | 13 | $652 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 49 | $640 |
| Pfizer | 30 | $636 |
| Madrigal Pharmaceuticals | 9 | $438 |
| QOL Medical, LLC | 13 | $434 |
| Phathom Pharmaceuticals, Inc. | 15 | $331 |
| Sanofi | 8 | $311 |
| Ferring Pharmaceuticals Inc. | 12 | $252 |
| Ardelyx, Inc. | 11 | $238 |
| Bristol Myers Squibb | 11 | $210 |
| Gilead | 10 | $192 |
| Regeneron Healthcare Solutions, Inc. | 8 | $192 |
| Medtronic | 2 | $192 |
| Nestle Healthcare Nutrition Inc. | 14 | $186 |
| Ipsen Biopharmaceuticals, Inc | 7 | $145 |
| Daiichi Sankyo Inc. | 5 | $130 |
| Janssen Scientific Affairs, LLC | 1 | $118 |
| Intercept Pharmaceuticals, Inc. | 6 | $112 |
| Aimmune Therapeutics, Inc. | 6 | $111 |
| E.r. Squibb & Sons, L.L.C. | 1 | $100 |
| Redhill Biopharma Inc. | 3 | $80 |
| Novo Nordisk | 3 | $69 |
| Boehringer Ingelheim | 3 | $48 |
| Braintree Laboratories, Inc. | 2 | $36 |
| Amgen | 1 | $34 |
| Sandoz | 1 | $33 |
| Orphalan Inc | 2 | $32 |
| Organon | 2 | $31 |
| Exact Sciences | 2 | $28 |
| Merck | 1 | $24 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Capsovision, Inc. | 1 | $17 |
| Ironwood Pharmaceuticals, Inc | 1 | $17 |
| Pharmacosmos Therapeutics Inc. | 1 | $16 |
| Evoke Pharma, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,926 in reported general payments places this provider in the 95th percentile of 2,888 physician assistant providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 18 | $267,878 |
| XifaxanRifaximin | 33 | $94,666 |
| LinzessLinaclotide | 63 | $65,020 |
| Mesalamine | 57 | $41,265 |
| IbsrelaTenapanor Hcl | 11 | $16,082 |
| Mesalamine ErMesalamine | 19 | $10,828 |
| Pantoprazole Sodium | 655 | $9,557 |
| MotegrityPrucalopride Succinate | 13 | $6,718 |
| Dexlansoprazole DrDexlansoprazole | 18 | $5,525 |
| Dicyclomine Hcl | 109 | $4,152 |
| Omeprazole | 153 | $2,767 |
| Famotidine | 150 | $2,536 |
| Sucralfate | 34 | $2,298 |
| Mercaptopurine | 12 | $2,140 |
| Esomeprazole Magnesium | 45 | $1,986 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan | $640 | $94,66633 claims |
| AbbVieLinzess | $3,328 | $65,02063 claims |
| Ardelyx, Inc.Ibsrela | $238 | $16,08211 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Motegrity | $1,778 | $6,71813 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,888 physician assistant providers in Arizona.
Other physician assistant in Chandler
- Danielle ZitekChandler$24K
- Joan AltmanChandler$16K
- Carly HopkinsChandler$14K
- Julie SilverChandler$14K
- Jenna HiltonGilbert$637K
- Kara GoodingScottsdale$625K
- Ginna GranrothScottsdale$211K
- Nicole MaderaGlendale$128K
- Candace RyanGlendale$113K
- Christopher BeroScottsdale$81K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.